742600login-checkProtein that drives liver damage could be a new target for treatment |
Yale researchers have identified a protein that drives symptoms of severe liver disease and may be a target for treatment in the future.
By Mallory Locklear
A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications. In a new study, Yale researchers have identified a driver of liver damage that occurs in NASH and which may open new treatment options in the future.
The study was published Sept. 27 in Science Translational Medicine. Read more in YaleNews.
742600login-checkProtein that drives liver damage could be a new target for treatment |